Latigo Biotherapeutics, Inc. is a private, early-stage biotechnology company focused on discovering and developing the next generation of non-opioid medicines for pain and pain-related syndromes.
The Senior Director of Toxicology will provide strategic and scientific leadership for all aspects of nonclinical safety and toxicology across Latigoâs discovery and development pipeline. This role is accountable for defining and executing phase-appropriate nonclinical safety strategies to support candidate selection, IND-enabling activities, first-in-human (FIH) studies, and overall clinical development for small molecule programs.
Neurocrine Biosciences